Before you sell to, join or invest in Cyclacel Pharmaceuticals, Inc.
MentionFox check on Cyclacel Pharmaceuticals, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/cyclacel-pharmaceuticals-inc-form-d-25000001
Check Cyclacel Pharmaceuticals, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Cyclacel Pharmaceuticals, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Cyclacel Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2025-03-25.
Cyclacel Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on March 25, 2025. The filing reports $1M sold. Its industry group is Biotechnology. It names Datuk Dr. Doris Wong Sing Ee (The Chief Executive Officer), Kiu Seng (The Chief Financial Officer), Kwang Chong (Director) (SEC Form D, March 25, 2025).
Is this your company?
Sell to companies like Cyclacel Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-03-25 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Cyclacel Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Cyclacel Pharmaceuticals, Inc., from the filings we hold.
Biotechnology raises by companies based in New Jersey, filed within 90 days of this one, largest first.
Get an email when Cyclacel Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Cyclacel Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Cyclacel Pharmaceuticals, Inc. →Get the full cited report on Cyclacel Pharmaceuticals, Inc.
What the filing shows about Cyclacel Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cyclacel Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Cyclacel Pharmaceuticals, Inc.'s address as 200 Connell Drive, Suite 1500, Berkeley Heights, NJ 07922.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Cyclacel Pharmaceuticals, Inc. See pricing
Cyclacel Pharmaceuticals, Inc. is a registered filer with the SEC (CIK 1130166) and has filed since 2024-05-17. 5 filings are on record, the latest on 2025-03-25.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Cyclacel Pharmaceuticals, Inc.'s Form D of 2025-03-25 names Datuk Dr. Doris Wong Sing Ee, Kiu Seng, Kwang Chong and 2 more as its officers, directors or promoters.
Its new offerings report $11.06M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
On the filing as: Executive Officer.
Datuk Dr. Doris Wong Sing Ee is named as The Chief Executive Officer on the Form D that Cyclacel Pharmaceuticals, Inc. filed with the SEC on 25 March 2025, one of 5 people that filing names.
On the filing as: Executive Officer.
Kiu Seng is named as The Chief Financial Officer on the Form D that Cyclacel Pharmaceuticals, Inc. filed with the SEC on 25 March 2025, one of 5 people that filing names.
Kwang Chong is named as Director on the Form D that Cyclacel Pharmaceuticals, Inc. filed with the SEC on 25 March 2025, one of 5 people that filing names.
David Natan is named as Director on the Form D that Cyclacel Pharmaceuticals, Inc. filed with the SEC on 25 March 2025, one of 5 people that filing names.
Avraham Ben-Tzvi is named as Director on the Form D that Cyclacel Pharmaceuticals, Inc. filed with the SEC on 25 March 2025, one of 5 people that filing names.
5 people named on the filing — 2 holding an executive role and 3 as directors only.
Named as of the 2025-03-25 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Cyclacel Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cyclacel Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cyclacel Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Cyclacel Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Cyclacel Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Cyclacel Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cyclacel-pharmaceuticals-inc-form-d-25000001